Literature DB >> 19595736

Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance.

Ping Zheng1.   

Abstract

Neuroactive steroids refer to steroids that are capable of regulating neuronal activities. Neuroactive steroids, synthesized either de novo in the nervous tissue or in the peripheral endocrine glands or as synthetic steroids, have exhibited numerous important modulatory effects on brain functions and brain diseases. At the cellular level, in addition to the effect on postsynaptic receptors, most neuroactive steroids, including pregnenolone, pregnenolone sulfate, progesterone, allopregnanolone, dehydroepiandrosterone, dehydroepiandrosterone sulfate, testosterone and estradiol, have modulatory effects on the release of multiple neurotransmitters like glutamate, GABA, acetylcholine, norepinephrine, dopamine and 5-HT. Many of these effects occur in the brain regions involved in learning and memory, emotion, motivation, motor and cognition. Moreover, the effects are rather complicated, maybe depending on many factors such as types of neuroactive steroids, brain regions and presynaptic functional states. The mechanisms are also complicated. Many of them involve rapid non-genomic effects on presynaptic receptors and ion channels like sigma-1 receptor, alpha(1) receptor, nicotine receptor, D1 receptor, NMDA receptor, GABA(A) receptor and L-type Ca(2+) channels. These effects have made neuroactive steroids important regulators of synaptic transmission in the central nervous system and constitute the major basis for many important actions of neuroactive steroids on brain functions and brain diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19595736     DOI: 10.1016/j.pneurobio.2009.07.001

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  78 in total

1.  Pregnenolone sulfate and cortisol induce secretion of acyl-CoA-binding protein and its conversion into endozepines from astrocytes.

Authors:  William F Loomis; M Margarita Behrens; Megan E Williams; Christophe Anjard
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  Mechanisms responsible for progesterone's protection against lordosis-inhibiting effects of restraint I. Role of progesterone receptors.

Authors:  James Hassell; Chandra Suma Johnson Miryala; Cindy Hiegel; Lynda Uphouse
Journal:  Horm Behav       Date:  2011-05-20       Impact factor: 3.587

3.  Activation of steroid-sensitive TRPM3 channels potentiates glutamatergic transmission at cerebellar Purkinje neurons from developing rats.

Authors:  Paula A Zamudio-Bulcock; Julie Everett; Christian Harteneck; C Fernando Valenzuela
Journal:  J Neurochem       Date:  2011-09-28       Impact factor: 5.372

4.  Modulation by pregnenolone sulfate of filtering properties in the hippocampal trisynaptic circuit.

Authors:  Chessa S Scullin; L Donald Partridge
Journal:  Hippocampus       Date:  2012-05-31       Impact factor: 3.899

5.  Allopregnanolone association with psychophysiological and cognitive functions during acute smoking abstinence in premenopausal women.

Authors:  Alicia M Allen; Mustafa al'Absi; Harry Lando; Sharon S Allen
Journal:  Exp Clin Psychopharmacol       Date:  2015-02       Impact factor: 3.157

6.  Brain serotonergic circuitries.

Authors:  Yves Charnay; Lucienne Léger
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

7.  A steroid modulatory domain in NR2A collaborates with NR1 exon-5 to control NMDAR modulation by pregnenolone sulfate and protons.

Authors:  Emmanuel Kostakis; Ming-Kuei Jang; Shelley J Russek; Terrell T Gibbs; David H Farb
Journal:  J Neurochem       Date:  2011-09-28       Impact factor: 5.372

Review 8.  Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?

Authors:  Shannon K Crowley; Susan S Girdler
Journal:  Psychopharmacology (Berl)       Date:  2014-04-23       Impact factor: 4.530

9.  Exogenous progesterone for smoking cessation in men and women: a pilot double-blind, placebo-controlled randomized clinical trial.

Authors:  Nicole L Tosun; Ann M Fieberg; Lynn E Eberly; Katherine A Harrison; Angela R Tipp; Alicia M Allen; Sharon S Allen
Journal:  Addiction       Date:  2019-06-17       Impact factor: 6.526

10.  TRPM3 channel stimulated by pregnenolone sulphate in synovial fibroblasts and negatively coupled to hyaluronan.

Authors:  Coziana Ciurtin; Yasser Majeed; Jacqueline Naylor; Piruthivi Sukumar; Anne A English; Paul Emery; David J Beech
Journal:  BMC Musculoskelet Disord       Date:  2010-06-04       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.